

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chemical homeostasis within a tissue (GO:0048875) | 7.67109966 |
| 2 | surfactant homeostasis (GO:0043129) | 7.59291419 |
| 3 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.89869640 |
| 4 | muscle filament sliding (GO:0030049) | 4.82353908 |
| 5 | actin-myosin filament sliding (GO:0033275) | 4.82353908 |
| 6 | cellular response to nitric oxide (GO:0071732) | 4.51247248 |
| 7 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.23610610 |
| 8 | axon extension involved in axon guidance (GO:0048846) | 4.23610610 |
| 9 | regulation of vasculogenesis (GO:2001212) | 4.23501212 |
| 10 | positive regulation of vasculogenesis (GO:2001214) | 4.14849960 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.05120593 |
| 12 | actin-mediated cell contraction (GO:0070252) | 3.93809433 |
| 13 | cellular response to reactive nitrogen species (GO:1902170) | 3.88229344 |
| 14 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.86882171 |
| 15 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.83943451 |
| 16 | myofibril assembly (GO:0030239) | 3.82307363 |
| 17 | cell proliferation involved in metanephros development (GO:0072203) | 3.80656588 |
| 18 | cell migration involved in heart development (GO:0060973) | 3.77616381 |
| 19 | skeletal muscle contraction (GO:0003009) | 3.76003780 |
| 20 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.62837867 |
| 21 | cardiac myofibril assembly (GO:0055003) | 3.62837332 |
| 22 | negative regulation of vascular permeability (GO:0043116) | 3.62016748 |
| 23 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.54512288 |
| 24 | respiratory gaseous exchange (GO:0007585) | 3.50310830 |
| 25 | regulation of relaxation of muscle (GO:1901077) | 3.49874434 |
| 26 | fibroblast migration (GO:0010761) | 3.45193429 |
| 27 | regulation of glomerular filtration (GO:0003093) | 3.43423145 |
| 28 | ethanol oxidation (GO:0006069) | 3.37223018 |
| 29 | negative regulation of complement activation (GO:0045916) | 3.31668495 |
| 30 | regulation of sequestering of triglyceride (GO:0010889) | 3.27473709 |
| 31 | myotube differentiation (GO:0014902) | 3.26517845 |
| 32 | striated muscle contraction (GO:0006941) | 3.22719865 |
| 33 | regulation of skeletal muscle contraction (GO:0014819) | 3.21154901 |
| 34 | sarcomere organization (GO:0045214) | 3.16419166 |
| 35 | cardiac muscle contraction (GO:0060048) | 3.12189092 |
| 36 | response to nitric oxide (GO:0071731) | 3.11009513 |
| 37 | lung-associated mesenchyme development (GO:0060484) | 3.10902935 |
| 38 | regulation of cell communication by electrical coupling (GO:0010649) | 3.06401609 |
| 39 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.05970300 |
| 40 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.05505888 |
| 41 | cell proliferation involved in kidney development (GO:0072111) | 3.05273189 |
| 42 | actin filament-based movement (GO:0030048) | 3.04944414 |
| 43 | regulation of p38MAPK cascade (GO:1900744) | 3.02616531 |
| 44 | cellular response to epinephrine stimulus (GO:0071872) | 3.01891779 |
| 45 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.01876772 |
| 46 | skeletal muscle fiber development (GO:0048741) | 2.99026463 |
| 47 | regulation of actin filament-based movement (GO:1903115) | 2.98324102 |
| 48 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.97866232 |
| 49 | response to inactivity (GO:0014854) | 2.97285599 |
| 50 | lung lobe morphogenesis (GO:0060463) | 2.96452413 |
| 51 | extracellular fibril organization (GO:0043206) | 2.96362833 |
| 52 | myotube cell development (GO:0014904) | 2.95530759 |
| 53 | positive regulation of p38MAPK cascade (GO:1900745) | 2.90084271 |
| 54 | negative regulation of protein activation cascade (GO:2000258) | 2.86230945 |
| 55 | cGMP-mediated signaling (GO:0019934) | 2.83844023 |
| 56 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.81655347 |
| 57 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.81347532 |
| 58 | muscle contraction (GO:0006936) | 2.81223944 |
| 59 | response to epinephrine (GO:0071871) | 2.80426484 |
| 60 | positive regulation of receptor recycling (GO:0001921) | 2.78872389 |
| 61 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.78415522 |
| 62 | lung vasculature development (GO:0060426) | 2.77405988 |
| 63 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.74434999 |
| 64 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.73581291 |
| 65 | toxin metabolic process (GO:0009404) | 2.73158567 |
| 66 | extracellular matrix assembly (GO:0085029) | 2.73098809 |
| 67 | actomyosin structure organization (GO:0031032) | 2.66434739 |
| 68 | muscle fiber development (GO:0048747) | 2.66279201 |
| 69 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.63752045 |
| 70 | creatine metabolic process (GO:0006600) | 2.61745675 |
| 71 | glomerular filtration (GO:0003094) | 2.60110895 |
| 72 | muscle cell cellular homeostasis (GO:0046716) | 2.56821409 |
| 73 | fatty acid transmembrane transport (GO:1902001) | 2.54700836 |
| 74 | transcytosis (GO:0045056) | 2.54315830 |
| 75 | negative regulation of catenin import into nucleus (GO:0035414) | 2.52292456 |
| 76 | endocrine hormone secretion (GO:0060986) | 2.52180997 |
| 77 | regulation of endothelial cell differentiation (GO:0045601) | 2.51770676 |
| 78 | cGMP biosynthetic process (GO:0006182) | 2.51565081 |
| 79 | skeletal muscle tissue development (GO:0007519) | 2.50475448 |
| 80 | polyol transport (GO:0015791) | 2.50421772 |
| 81 | mesenchymal cell proliferation (GO:0010463) | 2.50294497 |
| 82 | muscle system process (GO:0003012) | 2.49353306 |
| 83 | triglyceride catabolic process (GO:0019433) | 2.48393418 |
| 84 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.48360281 |
| 85 | adult heart development (GO:0007512) | 2.46622657 |
| 86 | lymph vessel development (GO:0001945) | 2.46173885 |
| 87 | ethanol metabolic process (GO:0006067) | 2.46120166 |
| 88 | negative regulation of humoral immune response (GO:0002921) | 2.45265651 |
| 89 | regulation of vascular permeability (GO:0043114) | 2.44598271 |
| 90 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.43300193 |
| 91 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.42780114 |
| 92 | endothelium development (GO:0003158) | 2.42068658 |
| 93 | glucan biosynthetic process (GO:0009250) | 2.42058558 |
| 94 | glycogen biosynthetic process (GO:0005978) | 2.42058558 |
| 95 | cardiac muscle hypertrophy (GO:0003300) | 2.42024477 |
| 96 | fibril organization (GO:0097435) | 2.41119457 |
| 97 | carnitine shuttle (GO:0006853) | 2.40359349 |
| 98 | striated muscle hypertrophy (GO:0014897) | 2.38103483 |
| 99 | muscle tissue morphogenesis (GO:0060415) | 2.37710638 |
| 100 | hippo signaling (GO:0035329) | 2.37051847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.03205272 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.01529817 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.77586246 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54271181 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.45987474 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.45619619 |
| 7 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.31643394 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.16275168 |
| 9 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09689314 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08125319 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07981117 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06807452 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.06553629 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.06553629 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.03931678 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01423430 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.98492918 |
| 18 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.98440424 |
| 19 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.98440424 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.97194362 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.90833382 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88294613 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.85285600 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82819532 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82021694 |
| 26 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.81816950 |
| 27 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.79670364 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.71503907 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68162901 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65470512 |
| 31 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.63655748 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.63025709 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.62171480 |
| 34 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.53347909 |
| 35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.47480017 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47467663 |
| 37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46100351 |
| 38 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45074739 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42576101 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42399219 |
| 41 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.42321049 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41177369 |
| 43 | CJUN_26792858_Chip-Seq_BT549_Human | 1.37214556 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35401702 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.35300454 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33790155 |
| 47 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.32505118 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32010335 |
| 49 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29848154 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29508719 |
| 51 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29309997 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27536837 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25460442 |
| 54 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.24716084 |
| 55 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.24344524 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23984623 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23984623 |
| 58 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23340338 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22349453 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19766882 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18466195 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18295882 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17834016 |
| 64 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16390593 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16244264 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14711358 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14549781 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12556295 |
| 69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12527087 |
| 70 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12283815 |
| 71 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10226177 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07048130 |
| 73 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05473020 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04380357 |
| 75 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04318299 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04215723 |
| 77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03722393 |
| 78 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.01131864 |
| 79 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.00973766 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00039166 |
| 81 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99744239 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97123639 |
| 83 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96745178 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95623784 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94929244 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94739076 |
| 87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93003560 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92868130 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91537587 |
| 90 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91343085 |
| 91 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.91275447 |
| 92 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.91183732 |
| 93 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.91022909 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91004171 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90962289 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90783643 |
| 97 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90687997 |
| 98 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90074373 |
| 99 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89195264 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89022508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 3.89658489 |
| 2 | MP0001958_emphysema | 3.53295032 |
| 3 | MP0004782_abnormal_surfactant_physiolog | 3.46509838 |
| 4 | MP0005670_abnormal_white_adipose | 3.22963672 |
| 5 | MP0010368_abnormal_lymphatic_system | 3.08043943 |
| 6 | MP0006138_congestive_heart_failure | 2.80813205 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 2.77580216 |
| 8 | MP0005503_abnormal_tendon_morphology | 2.67054523 |
| 9 | MP0005275_abnormal_skin_tensile | 2.66427556 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.52188833 |
| 11 | MP0000749_muscle_degeneration | 2.48574166 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.47627217 |
| 13 | MP0003646_muscle_fatigue | 2.33495257 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.33347367 |
| 15 | MP0004130_abnormal_muscle_cell | 2.32489417 |
| 16 | MP0000566_synostosis | 2.26671557 |
| 17 | MP0001879_abnormal_lymphatic_vessel | 2.15199664 |
| 18 | MP0004272_abnormal_basement_membrane | 2.08663178 |
| 19 | MP0005330_cardiomyopathy | 2.05625702 |
| 20 | MP0003950_abnormal_plasma_membrane | 2.03392541 |
| 21 | MP0005666_abnormal_adipose_tissue | 1.99785947 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.98588932 |
| 23 | MP0004087_abnormal_muscle_fiber | 1.98034444 |
| 24 | MP0002102_abnormal_ear_morphology | 1.93051942 |
| 25 | MP0002106_abnormal_muscle_physiology | 1.87319259 |
| 26 | MP0001544_abnormal_cardiovascular_syste | 1.85253264 |
| 27 | MP0005385_cardiovascular_system_phenoty | 1.85253264 |
| 28 | MP0002108_abnormal_muscle_morphology | 1.84419772 |
| 29 | MP0005369_muscle_phenotype | 1.77629884 |
| 30 | MP0000759_abnormal_skeletal_muscle | 1.76356186 |
| 31 | MP0002332_abnormal_exercise_endurance | 1.76223990 |
| 32 | MP0008995_early_reproductive_senescence | 1.73927629 |
| 33 | MP0005620_abnormal_muscle_contractility | 1.73417232 |
| 34 | MP0004215_abnormal_myocardial_fiber | 1.73251876 |
| 35 | MP0000747_muscle_weakness | 1.69363802 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.65214241 |
| 37 | MP0002972_abnormal_cardiac_muscle | 1.64108182 |
| 38 | MP0005388_respiratory_system_phenotype | 1.53917141 |
| 39 | MP0002133_abnormal_respiratory_system | 1.53917141 |
| 40 | MP0005375_adipose_tissue_phenotype | 1.51534730 |
| 41 | MP0004484_altered_response_of | 1.49187586 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.48467022 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.46380607 |
| 44 | MP0008004_abnormal_stomach_pH | 1.46181024 |
| 45 | MP0000750_abnormal_muscle_regeneration | 1.44235325 |
| 46 | MP0002971_abnormal_brown_adipose | 1.43341741 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.40373495 |
| 48 | MP0005595_abnormal_vascular_smooth | 1.40107263 |
| 49 | MP0003828_pulmonary_edema | 1.39678837 |
| 50 | MP0003283_abnormal_digestive_organ | 1.36156856 |
| 51 | MP0001984_abnormal_olfaction | 1.32776211 |
| 52 | MP0003091_abnormal_cell_migration | 1.28392145 |
| 53 | MP0000462_abnormal_digestive_system | 1.27803810 |
| 54 | MP0001542_abnormal_bone_strength | 1.26223548 |
| 55 | MP0002269_muscular_atrophy | 1.25506094 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.24779165 |
| 57 | MP0003279_aneurysm | 1.23786740 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.22439715 |
| 59 | MP0010630_abnormal_cardiac_muscle | 1.22250414 |
| 60 | MP0008775_abnormal_heart_ventricle | 1.21069199 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.19570339 |
| 62 | MP0003941_abnormal_skin_development | 1.19298552 |
| 63 | MP0003011_delayed_dark_adaptation | 1.17746731 |
| 64 | MP0001177_atelectasis | 1.17256497 |
| 65 | MP0001661_extended_life_span | 1.06182044 |
| 66 | MP0003115_abnormal_respiratory_system | 1.05413616 |
| 67 | MP0000767_abnormal_smooth_muscle | 1.05004798 |
| 68 | MP0005508_abnormal_skeleton_morphology | 1.00640234 |
| 69 | MP0005165_increased_susceptibility_to | 1.00123372 |
| 70 | MP0003303_peritoneal_inflammation | 0.97763447 |
| 71 | MP0005171_absent_coat_pigmentation | 0.97639623 |
| 72 | MP0002128_abnormal_blood_circulation | 0.95999778 |
| 73 | MP0003724_increased_susceptibility_to | 0.95997866 |
| 74 | MP0005164_abnormal_response_to | 0.95012105 |
| 75 | MP0000733_abnormal_muscle_development | 0.93925347 |
| 76 | MP0004085_abnormal_heartbeat | 0.93888195 |
| 77 | MP0004883_abnormal_blood_vessel | 0.92022099 |
| 78 | MP0003137_abnormal_impulse_conducting | 0.90605984 |
| 79 | MP0000003_abnormal_adipose_tissue | 0.89449145 |
| 80 | MP0002127_abnormal_cardiovascular_syste | 0.89156677 |
| 81 | MP0000343_altered_response_to | 0.87075016 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 0.85748111 |
| 83 | MP0001175_abnormal_lung_morphology | 0.81868604 |
| 84 | MP0000049_abnormal_middle_ear | 0.79707894 |
| 85 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79080290 |
| 86 | MP0001851_eye_inflammation | 0.76716259 |
| 87 | MP0000249_abnormal_blood_vessel | 0.75670818 |
| 88 | MP0000534_abnormal_ureter_morphology | 0.75458821 |
| 89 | MP0000266_abnormal_heart_morphology | 0.74332095 |
| 90 | MP0003690_abnormal_glial_cell | 0.73464800 |
| 91 | MP0001299_abnormal_eye_distance/ | 0.72185580 |
| 92 | MP0009250_abnormal_appendicular_skeleto | 0.70588127 |
| 93 | MP0003385_abnormal_body_wall | 0.70488486 |
| 94 | MP0005334_abnormal_fat_pad | 0.70437570 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.69744247 |
| 96 | MP0003948_abnormal_gas_homeostasis | 0.68588141 |
| 97 | MP0009115_abnormal_fat_cell | 0.68020527 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.66113741 |
| 99 | MP0005535_abnormal_body_temperature | 0.65291168 |
| 100 | MP0001614_abnormal_blood_vessel | 0.65148768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 6.13038331 |
| 2 | Interstitial pulmonary disease (HP:0006530) | 6.03330324 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 6.02200082 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.86334853 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 5.74164693 |
| 6 | Muscle fiber splitting (HP:0003555) | 4.66510114 |
| 7 | Bundle branch block (HP:0011710) | 4.50414764 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 4.28480558 |
| 9 | Exercise-induced myalgia (HP:0003738) | 4.25981231 |
| 10 | Increased connective tissue (HP:0009025) | 4.11515918 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.81197255 |
| 12 | Asymmetric septal hypertrophy (HP:0001670) | 3.73834466 |
| 13 | Distal arthrogryposis (HP:0005684) | 3.72207063 |
| 14 | Sudden death (HP:0001699) | 3.68437335 |
| 15 | Round ear (HP:0100830) | 3.62096988 |
| 16 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.54390304 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 3.49226451 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 3.49159873 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 3.39602656 |
| 20 | Increased variability in muscle fiber diameter (HP:0003557) | 3.36543517 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 3.33346456 |
| 22 | Difficulty running (HP:0009046) | 3.32940220 |
| 23 | Heart block (HP:0012722) | 3.32594027 |
| 24 | Myotonia (HP:0002486) | 3.28452287 |
| 25 | Abnormal atrioventricular conduction (HP:0005150) | 3.26631479 |
| 26 | Myoglobinuria (HP:0002913) | 3.25899901 |
| 27 | Tubulointerstitial fibrosis (HP:0005576) | 3.22248014 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.09067373 |
| 29 | Distal lower limb muscle weakness (HP:0009053) | 3.03611554 |
| 30 | Neck muscle weakness (HP:0000467) | 3.02998621 |
| 31 | Aortic aneurysm (HP:0004942) | 2.97563973 |
| 32 | Frequent falls (HP:0002359) | 2.96110460 |
| 33 | Complement deficiency (HP:0004431) | 2.95195000 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 2.84291996 |
| 35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.80982872 |
| 36 | Subaortic stenosis (HP:0001682) | 2.80982872 |
| 37 | Respiratory distress (HP:0002098) | 2.80606668 |
| 38 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.78329942 |
| 39 | Spinal rigidity (HP:0003306) | 2.74829877 |
| 40 | Atrioventricular block (HP:0001678) | 2.69350295 |
| 41 | Myopathic facies (HP:0002058) | 2.60494196 |
| 42 | Hyperkalemia (HP:0002153) | 2.59138290 |
| 43 | Lipoatrophy (HP:0100578) | 2.58773307 |
| 44 | Midline defect of the nose (HP:0004122) | 2.50150525 |
| 45 | Rimmed vacuoles (HP:0003805) | 2.48427676 |
| 46 | Protrusio acetabuli (HP:0003179) | 2.48293502 |
| 47 | Oligomenorrhea (HP:0000876) | 2.46938245 |
| 48 | Atrial fibrillation (HP:0005110) | 2.43624395 |
| 49 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.40236074 |
| 50 | Calcaneovalgus deformity (HP:0001848) | 2.40089502 |
| 51 | Lymphangioma (HP:0100764) | 2.38417410 |
| 52 | Tachypnea (HP:0002789) | 2.37247488 |
| 53 | Abnormality of complement system (HP:0005339) | 2.36763302 |
| 54 | Dilated cardiomyopathy (HP:0001644) | 2.29913303 |
| 55 | Polycythemia (HP:0001901) | 2.25808637 |
| 56 | Primary atrial arrhythmia (HP:0001692) | 2.22830710 |
| 57 | Abnormality of the foot musculature (HP:0001436) | 2.20850183 |
| 58 | Syncope (HP:0001279) | 2.19425779 |
| 59 | Hip contracture (HP:0003273) | 2.17154240 |
| 60 | Ulnar deviation of the wrist (HP:0003049) | 2.13648805 |
| 61 | Pulmonary artery stenosis (HP:0004415) | 2.12144262 |
| 62 | Vascular tortuosity (HP:0004948) | 2.12041610 |
| 63 | Prolonged QT interval (HP:0001657) | 2.11220939 |
| 64 | Tubulointerstitial abnormality (HP:0001969) | 2.11114774 |
| 65 | Abnormality of the ischium (HP:0003174) | 2.10669142 |
| 66 | Striae distensae (HP:0001065) | 2.10468145 |
| 67 | Ventricular tachycardia (HP:0004756) | 2.10373875 |
| 68 | Broad metatarsal (HP:0001783) | 2.08591146 |
| 69 | Glomerulonephritis (HP:0000099) | 2.07681128 |
| 70 | Foot dorsiflexor weakness (HP:0009027) | 2.06644739 |
| 71 | Deformed tarsal bones (HP:0008119) | 2.06366780 |
| 72 | Supraventricular tachycardia (HP:0004755) | 2.05650655 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.05424936 |
| 74 | Muscle stiffness (HP:0003552) | 2.04129687 |
| 75 | Supraventricular arrhythmia (HP:0005115) | 2.02137856 |
| 76 | Proximal amyotrophy (HP:0007126) | 2.01650184 |
| 77 | Cerebral aneurysm (HP:0004944) | 1.95625226 |
| 78 | Ventricular arrhythmia (HP:0004308) | 1.94650443 |
| 79 | Absent phalangeal crease (HP:0006109) | 1.94305304 |
| 80 | Generalized muscle weakness (HP:0003324) | 1.93879321 |
| 81 | Slender build (HP:0001533) | 1.91285787 |
| 82 | Scapular winging (HP:0003691) | 1.86486376 |
| 83 | Skin nodule (HP:0200036) | 1.85403117 |
| 84 | Bulbar palsy (HP:0001283) | 1.83562547 |
| 85 | Aplasia of the musculature (HP:0100854) | 1.79001543 |
| 86 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.75808782 |
| 87 | Abnormality of the calcaneus (HP:0008364) | 1.74744722 |
| 88 | Mitral valve prolapse (HP:0001634) | 1.74328885 |
| 89 | Exertional dyspnea (HP:0002875) | 1.73721386 |
| 90 | Limited hip movement (HP:0008800) | 1.73297043 |
| 91 | Areflexia of lower limbs (HP:0002522) | 1.73012730 |
| 92 | Gowers sign (HP:0003391) | 1.72442462 |
| 93 | Pulmonary hypertension (HP:0002092) | 1.71279970 |
| 94 | Acanthosis nigricans (HP:0000956) | 1.70687619 |
| 95 | Camptodactyly of toe (HP:0001836) | 1.70296985 |
| 96 | Nonprogressive disorder (HP:0003680) | 1.66306759 |
| 97 | EMG: neuropathic changes (HP:0003445) | 1.65958977 |
| 98 | Ventricular fibrillation (HP:0001663) | 1.64220810 |
| 99 | Incomplete penetrance (HP:0003829) | 1.63557779 |
| 100 | Rapidly progressive (HP:0003678) | 1.62954745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.09183678 |
| 2 | TTN | 3.83772394 |
| 3 | TIE1 | 3.43794260 |
| 4 | MYLK | 2.72496095 |
| 5 | NEK9 | 2.58319325 |
| 6 | EPHB2 | 2.51449260 |
| 7 | RIPK1 | 2.44039853 |
| 8 | DDR2 | 2.41855821 |
| 9 | LATS2 | 2.35511972 |
| 10 | TGFBR2 | 2.30098824 |
| 11 | LATS1 | 2.28766608 |
| 12 | PHKG2 | 2.25609482 |
| 13 | PHKG1 | 2.25609482 |
| 14 | MARK1 | 2.09471969 |
| 15 | ICK | 1.92743321 |
| 16 | PIK3CG | 1.84056049 |
| 17 | MAP3K7 | 1.83239194 |
| 18 | MAP3K6 | 1.59267925 |
| 19 | MAPK7 | 1.52611963 |
| 20 | DMPK | 1.47684676 |
| 21 | MAPK15 | 1.46890138 |
| 22 | PDGFRA | 1.46676543 |
| 23 | KDR | 1.32147766 |
| 24 | TRPM7 | 1.32085199 |
| 25 | EEF2K | 1.28718820 |
| 26 | MAPK12 | 1.28709282 |
| 27 | GRK5 | 1.24425916 |
| 28 | TRIB3 | 1.22580278 |
| 29 | MAPK4 | 1.20405697 |
| 30 | MAP3K10 | 1.15222638 |
| 31 | PRKAA2 | 1.13926229 |
| 32 | PINK1 | 1.13518235 |
| 33 | MAPKAPK3 | 1.11517691 |
| 34 | FGFR2 | 1.05656574 |
| 35 | PRKD1 | 1.04784384 |
| 36 | NTRK1 | 1.03929771 |
| 37 | LRRK2 | 1.02475600 |
| 38 | CAMK1 | 1.01120002 |
| 39 | FER | 1.00617918 |
| 40 | MARK2 | 0.97351194 |
| 41 | MOS | 0.94911650 |
| 42 | LIMK1 | 0.92619957 |
| 43 | MET | 0.90983827 |
| 44 | CDC42BPA | 0.90892287 |
| 45 | DAPK2 | 0.88062137 |
| 46 | MAP3K4 | 0.86614862 |
| 47 | TESK1 | 0.85001269 |
| 48 | MST1R | 0.81861828 |
| 49 | MAP3K13 | 0.81332304 |
| 50 | PDGFRB | 0.73889824 |
| 51 | GRK7 | 0.72050536 |
| 52 | GSK3A | 0.70656683 |
| 53 | ALK | 0.68125376 |
| 54 | CAMK4 | 0.66640314 |
| 55 | NTRK3 | 0.64378522 |
| 56 | GRK1 | 0.63540059 |
| 57 | DYRK1B | 0.62022643 |
| 58 | ROCK1 | 0.60236575 |
| 59 | ABL2 | 0.59141611 |
| 60 | ZAP70 | 0.58880367 |
| 61 | PRKG1 | 0.57102097 |
| 62 | NLK | 0.55707602 |
| 63 | PDPK1 | 0.55257940 |
| 64 | ERBB3 | 0.54971649 |
| 65 | WNK1 | 0.54379260 |
| 66 | CDK3 | 0.53351693 |
| 67 | CAMK2G | 0.53123678 |
| 68 | AKT3 | 0.52319360 |
| 69 | UHMK1 | 0.52298767 |
| 70 | EPHB1 | 0.52215505 |
| 71 | STK38L | 0.49638524 |
| 72 | AKT2 | 0.47841198 |
| 73 | PAK3 | 0.47002975 |
| 74 | CAMK2A | 0.44918989 |
| 75 | RPS6KA3 | 0.44792191 |
| 76 | SGK2 | 0.44788158 |
| 77 | PKN1 | 0.44779245 |
| 78 | PDK2 | 0.44490651 |
| 79 | EPHA3 | 0.44064097 |
| 80 | CSNK1G2 | 0.43411829 |
| 81 | PRKACA | 0.43075827 |
| 82 | CAMKK2 | 0.41910795 |
| 83 | RPS6KL1 | 0.41846131 |
| 84 | RPS6KC1 | 0.41846131 |
| 85 | CAMK2B | 0.40937042 |
| 86 | PRKAA1 | 0.40677525 |
| 87 | STK24 | 0.40453068 |
| 88 | IRAK1 | 0.40219850 |
| 89 | RPS6KA6 | 0.39721101 |
| 90 | CAMK2D | 0.39382575 |
| 91 | ILK | 0.39198700 |
| 92 | PRKACG | 0.39169424 |
| 93 | MTOR | 0.38748194 |
| 94 | CASK | 0.38141853 |
| 95 | ADRBK1 | 0.37475906 |
| 96 | PAK2 | 0.36649659 |
| 97 | RPS6KA2 | 0.36567744 |
| 98 | MAPK9 | 0.36199067 |
| 99 | SIK1 | 0.34363952 |
| 100 | MAPK3 | 0.33837883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.08998684 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.02106507 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51547262 |
| 4 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.51313412 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.49940610 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.38336336 |
| 7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.34298325 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.21262138 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16581418 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.16127908 |
| 11 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.05142647 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.04718427 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 1.77656296 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.72969298 |
| 15 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58149973 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57661898 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 1.53134297 |
| 18 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.52807462 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51791358 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48108649 |
| 21 | Focal adhesion_Homo sapiens_hsa04510 | 1.41537714 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40959434 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.34721369 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.32729807 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.30442744 |
| 26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28953787 |
| 27 | ABC transporters_Homo sapiens_hsa02010 | 1.26287396 |
| 28 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.21260618 |
| 29 | Tight junction_Homo sapiens_hsa04530 | 1.18470951 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.15536962 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12988294 |
| 32 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.10893437 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10351851 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08737573 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02365976 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01524133 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01433187 |
| 38 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.99469732 |
| 39 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.98032967 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 0.94415918 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92985024 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 0.92646004 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.90403346 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 0.87893446 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87560567 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86786847 |
| 47 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.86604726 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.84515596 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84064247 |
| 50 | Asthma_Homo sapiens_hsa05310 | 0.83354372 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81109835 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77245216 |
| 53 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76508582 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.76496792 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.76459745 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75900227 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.72756183 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69422330 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68764366 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67183167 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.65488903 |
| 62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62699793 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.62364464 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.62356671 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62086543 |
| 66 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61897411 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61104110 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60112041 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60021281 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58608988 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57553753 |
| 72 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53465773 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52089185 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50862479 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50801878 |
| 76 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50216485 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50215273 |
| 78 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49380158 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47310885 |
| 80 | Melanoma_Homo sapiens_hsa05218 | 0.46886381 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46139861 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46063854 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.45974343 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44828529 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44420649 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42623967 |
| 87 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.40942938 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40895876 |
| 89 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38332144 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.38281490 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38041957 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37868827 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36061224 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34980856 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.34589608 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34366397 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34178916 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32045841 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30647760 |
| 100 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.30306803 |

